Duolingo Insider Notice: 5,754 Shares to Be Sold via Morgan Stanley
Rhea-AI Filing Summary
Duolingo, Inc. (DUOL) insider sale notice: The filing reports a proposed sale of 5,754 shares of Duolingo common stock through Morgan Stanley Smith Barney LLC with an approximate aggregate market value of $1,881,155.22. The filing lists the approximate date of sale as 08/18/2025 and reports 39,694,545 shares outstanding. The shares were acquired as Restricted Stock Units on 08/15/2024 and paid on that date. The form also discloses prior sales by the same person: 261 shares sold on 08/15/2025 for $85,877.67 and 2,709 shares sold under a Rule 10b5-1 plan on 07/01/2025 for $1,090,509.58.
Positive
- Transparent disclosure of the proposed sale including broker, share count, and aggregate market value
- Acquisition details provided showing the shares were received as restricted stock units on 08/15/2024
- Prior sales disclosed, including a Rule 10b5-1 plan sale on 07/01/2025, which enhances procedural transparency
Negative
- Insider share sale is being proposed, which could be viewed negatively by some market participants
- Filing lacks remarks or a stated 10b5-1 plan adoption date within the visible remarks section
Insights
TL;DR: Routine restricted-stock sale notice by an insider, disclosed with past 10b5-1 sales; no earnings data or company-specific operational details.
The filing documents a planned sale of 5,754 shares acquired as restricted stock units on 08/15/2024, to be executed through Morgan Stanley on or about 08/18/2025. Prior disposals of the filer are transparently reported, including a 10b5-1 plan sale on 07/01/2025. For investors, this is a standard insider liquidity event and the filing provides clear transaction dates and proceeds but does not include any operational or financial performance information about the company.
TL;DR: Proper Rule 144 disclosure of an insider sale with accompanying 10b5-1 sales history; appears procedurally compliant.
The notice identifies the securities, broker, acquisition type (RSUs), and prior sales, which aligns with disclosure expectations for Rule 144 transactions. The filer represents no undisclosed material adverse information, and the presence of documented 10b5-1 activity improves transparency. The filing lacks additional remarks or plan-adoption dates on its face, so no further governance context is provided.